RecruitingNCT04970472
Bio Clinical Collection of Urothelial Carcinoma
Sponsor
University Hospital, Toulouse
Enrollment
1,000 participants
Start Date
Nov 16, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this study is to collect tumor samples, urines, stool and blood from patients with urothelial carcinoma. These samples will be stored in a secure and confidential laboratory of the Toulouse University Hospital.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria3
- Adult \>18 years old
- Patient with suspected or diagnosed Urothelial carcinoma
- Patients who are willing to consent for this protocol.
Exclusion Criteria4
- Pregnant or breastfeeding patients
- Patients under 18 years old
- Patients under guardianship or curators
- Patients unable to sign a free and informed consent
Interventions
BIOLOGICALcollection of blood, urines, stool and tumor samples
blood, urines, stool will be collected during routine cares. Tumor samples from surgery will also be stored.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04970472
Related Trials
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT000268841 location
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
NCT0712999379 locations
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
NCT0697316127 locations
Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
NCT074754031 location
Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
NCT071802122 locations